Benzene Ring Attached Indirectly To The Sulfonate Group By Acyclic Nonionic Bonding Patents (Class 562/41)
  • Patent number: 10871711
    Abstract: A resist composition is provided comprising a base polymer containing an iodized polymer, and an acid generator containing a sulfonium salt and/or iodonium salt of iodized benzene ring-containing fluorosulfonic acid. When processed by lithography, the resist composition exhibits a high sensitivity, low LWR and improved CDU independent of whether it is of positive tone or negative tone.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: December 22, 2020
    Assignee: SHIN-ETSU CHEMICAL CO., LTD.
    Inventors: Jun Hatakeyama, Masaki Ohashi, Masahiro Fukushima, Takayuki Fujiwara
  • Patent number: 10323113
    Abstract: A resist composition comprising a base polymer and a sulfonium or iodonium salt of iodized benzoyloxy-containing fluorinated sulfonic acid offers a high sensitivity and minimal LWR or improved CDU independent of whether it is of positive or negative tone.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: June 18, 2019
    Assignee: SHIN-ETSU CHEMICAL CO., LTD.
    Inventors: Jun Hatakeyama, Masaki Ohashi, Takayuki Fujiwara, Masahiro Fukushima, Kazuya Honda
  • Patent number: 8969616
    Abstract: A process for the preparation of isosulfan blue (Active Pharmaceutical Ingredient) is provided. A process is also provided for preparation of the intermediate, 2-chlorobenzaldehyde-5-sulfonic acid, sodium salt of formula (2), used in the preparation thereof and a procedure for the isolation of benzaldehyde-2,5-disulfonic acid, di-sodium salt of the formula (3). Also provided is a process for the preparation of an isoleuco acid of formula (4), which upon mild oxidation gives rise to isosulfan blue of pharmaceutical grade which can be used for preparation of pharmaceutical formulations. The isolation and purification procedures provided in the process provide substantially pure isosulfan blue with HPLC purity 99.5% or greater.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: March 3, 2015
    Assignee: Apicore US LLC
    Inventors: Ravishanker Kovi, Satyam S. Nampalli, Peter Xavier Tharial
  • Publication number: 20140364601
    Abstract: Processes for the preparation of the compound of formula (II) and intermediate compounds for use in the processes.
    Type: Application
    Filed: May 11, 2012
    Publication date: December 11, 2014
    Applicant: ASTRAZENECA AB
    Inventors: Neil Barnwell, Philip Cornwall, Duncan Michael Gill, Gareth P. Howell, Rebecca Elizabeth Meadows, Andiappan Murugan, Philip O'Keefe, John Singleton, Jane Withnall, Eric Merifield, Christopher William Mitchell, Zakariya Mohamed Patel, James Barry Rose
  • Patent number: 8779183
    Abstract: An acid generating agent used for chemically amplified resist compositions is provided, which agent is represented by the following formula (1): wherein X represents a monocyclic or polycyclic hydrocarbon group having 3 to 30 carbon atoms, and having at least one hydrogen atom on the ring substituted by an alkyl or alkoxy group which may be unsubstituted or substituted with a group selected from an ether group, an ester group, a carbonyl group, an acetal group, an epoxy group, a nitrile group and an aldehyde group, or by a perfluoroalkyl group, a hydroxyalkyl group, or a cyano group; R6 is an alkyl group, an alkoxy group, or a heteroatom selected from the group consisting of N, S and F; m is an integer from 0 to 2; and A+ is an organic counterion.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: July 15, 2014
    Assignee: Korea Kumho Petrochemical Co., Ltd.
    Inventors: Jung-Hoon Oh, Dong-Cheol Seo, Hyun-Sang Joo, Chang-Soo Lee
  • Publication number: 20140163254
    Abstract: A sulfonium salt compound represented by the following general formula (I): where R1 and R2 each denote the same or a different alkyl group having 1 to 18 carbon atoms, R3 and R4 each denote the same or a different alkyl group having 1 to 10 carbon atoms, X? denotes a sulfonate anion or a carboxylate anion, and the substituents denoted by R3O and R4O are each located at an arbitrary position selected from the 2-position to the 8-position of the naphthyl group.
    Type: Application
    Filed: December 3, 2013
    Publication date: June 12, 2014
    Inventors: Hironori Kinoshita, Sumitsugu Kisanuki, Masaaki Sugi, Takayoshi Mori
  • Patent number: 8722937
    Abstract: The present invention provides N-alkylthio ?-lactams and disulfide compounds (e.g., alkyl-coenzyme A asymmetric disulfides or aryl-alkyl disulfides), compositions containing such compounds, and method of their use as anti-bacterial agents.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: May 13, 2014
    Assignee: University of South Florida
    Inventors: Edward Turos, Kevin D. Revell
  • Publication number: 20140093490
    Abstract: The present invention investigate the two modes of glutamate release and the releasing rate of glutamate, and thus can provide a useful technique for neuron protection and acceleration of neurotransmission by controlling the glutamate release in astroctye. Thus, the present invention provides an inhibitor of the fast-mode release and/or the slow-mode release of astrocytic glutamate, a screening method of the inhibitor and a pharmaceutical composition or method of ameliorating, preventing and/or treating the disease associated with the over-release of glutamate via the Ca2+-activated anion channel, with the inhibition of fast-mode glutamate release.
    Type: Application
    Filed: July 23, 2013
    Publication date: April 3, 2014
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Changjoon Justin LEE, Soo Jin OH, Eun Mi HWANG, Dong Ho WOO
  • Patent number: 8530138
    Abstract: The present invention provides a salt represented by the formula (I): wherein Q1 and Q2 independently each represent a fluorine atom or a C1-C6 perfluoroalkyl group, L1 and L2 independently each represent a C1-C17 divalent saturated hydrocarbon group in which one or more —CH2— can be replaced by —O— or —CO—, ring W1 and ring W2 independently each represent a C3-C36 aliphatic ring, R2 is independently in each occurrence a C1-C6 alkyl group, R4 is independently in each occurrence a C1-C6 alkyl group, R3 represents a C1-C12 hydrocarbon group, t represents an integer of 0 to 2, u represents an integer of 0 to 2, and Z+ represents an organic counter ion.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: September 10, 2013
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Isao Yoshida, Koji Ichikawa
  • Publication number: 20130203639
    Abstract: An overbased alkylated arylalkyl sulfonate is easy to prepare and is useful as a detergent in various lubricant applications.
    Type: Application
    Filed: January 11, 2011
    Publication date: August 8, 2013
    Applicant: THE LUBRIZOL CORPORATION
    Inventors: James P. Roski, Ewan E. Delbridge, Christopher Friend, Gary M. Walker, Virginia A. Carrick, Jonathan S. Vilardo
  • Patent number: 8440857
    Abstract: Sulfonate- or sulfate-capped, alkoxylated anti-misting agents having the structures: R((AO)nX)m((AO)nH)p and R3C(O)NH(CH2)zN+(CH3)2CH2CHR4CH2SO3?, and to methods of suppressing mist from electrolyte solutions by adding a mist-suppressing amount of one or more of said compounds to electrolyte solutions.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: May 14, 2013
    Assignee: BASF Corporation
    Inventors: Michael Virnig, Jack Bender, Louis Rebrovic
  • Patent number: 8288077
    Abstract: The object of the present invention is to provide a chemically amplified resist composition excellent in a resolution and a mask error enhancement factor. By employing the salt represented by the formulae (A1) as an acid generator of a resist composition, the above mentioned object is achieved. wherein Z+ represents an organic cation, Q1 and Q2 each independently represent a fluorine atom or a perfluoroalkyl group, Ra2 represents a divalent alicyclic hydrocarbon group pr the like, Ra2 represents an elimination group represented by the formulae (II-1) or (II-2). In the formulae (II-1) or (II-2), Ra3 and Ra4 each independently represent a hydrogen atom or an aliphatic hydrocarbon group, Ra5 represents an aliphatic hydrocarbon group, Ra6 represents a divalent aliphatic hydrocarbon group, and Ra7 represents an aliphatic hydrocarbon group.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: October 16, 2012
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Koji Ichikawa, Isao Yoshida, Satoshi Yamaguchi
  • Publication number: 20120252784
    Abstract: Novel 2,3,4-benzothiadiazepines-2,2-dioxides and processes for the preparation thereof are disclosed. The compounds influence the central nervous system and may be used to treat or prevent Alzheimer's disease, Parkinson's disease or Huntington's disease, senile dementia not of the Alzheimer's type, vascular dementia, post-stroke dementia, Korsakoff's syndrome, Down's syndrome, schizophrenia, panic disorder, post-traumatic stress disorder, anxiety or depression.
    Type: Application
    Filed: March 13, 2012
    Publication date: October 4, 2012
    Inventors: Jozsef FETTER, Ferenc BERTHA, Balazs MOLNAR, Gyula SIMIG, Jozsef BARKOCZY, Balazs VOLK, Gyoergy LEVAY, Istvan GACSALYI, Gabor GIGLER, Hajnalka KOMPAGNE, Bernadett MARKO, Katalin NAGY, Peter KIRICSI, Laszlo Gabor HARSING, Gabor SZENASI
  • Patent number: 8173354
    Abstract: A sulfonium salt having a triphenylsulfonium cation and a sulfite anion within the molecule is best suited as a photoacid generator in chemically amplified resist compositions. Upon exposure to high-energy radiation, the sulfonium salt generates a sulfonic acid, which facilitates efficient scission of acid labile groups in chemically amplified positive resist compositions. Because of substantial non-volatility under high vacuum conditions in the EB or EUV lithography, the risk of the exposure tool being contaminated is minimized.
    Type: Grant
    Filed: July 7, 2010
    Date of Patent: May 8, 2012
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventors: Youichi Ohsawa, Masaki Ohashi
  • Patent number: 8044100
    Abstract: Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: October 25, 2011
    Assignee: Bellus Health Inc.
    Inventors: Xianqi Kong, Xinfu Wu, Abderrahim Bouzide, Isabelle Valade, David Migneault, Francine Gervais, Daniel Delorme, Benoit Bachand, Mohamed Atfani, Sophie Levesque, Bita Samim
  • Publication number: 20110245110
    Abstract: Compounds represented by the following structural formulas can be used as photoacid generators: Such compounds are useful, for example, in fabricating arrays of polymers.
    Type: Application
    Filed: May 9, 2011
    Publication date: October 6, 2011
    Applicant: AFFYMETRIX, INC.
    Inventors: Glenn H. McGall, Andrea Cupoletti
  • Patent number: 8026390
    Abstract: An acid generator represented by the following formula (1) is provided: wherein X represents an alkylene group having 1 to 10 carbon atoms, —X1—O—X2—, or a heteroatom selected from the group consisting of nitrogen, sulfur and fluorine; X1 and X2 each independently represent an alkylene group having 1 to 10 carbon atoms; Y represents a cyclic hydrocarbon group having 5 to 30 carbon atoms and containing one or more aromatic rings, while one or more hydrogen atoms on the ring of the cyclic hydrocarbon group may be substituted by one or more members selected from the group consisting of —O—Y1, —CO—Y2, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 4 carbon atoms, a perfluoroalkoxy group having 1 to 4 carbon atoms, a hydroxyalkyl group having 1 to 6 carbon atoms, a halogen atom, a hydroxyl group and a cyano group; Y1 and Y2 each independently represent an alkyl group having 1 to 6 carbon atoms; n represents an integer of 0 or 5; and A+
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: September 27, 2011
    Assignee: Korea Kumho Petrochenicals Co., Ltd.
    Inventors: Jung-Hoon Oh, Dong-Cheol Seo, Jin-Bong Shin
  • Patent number: 7955777
    Abstract: There are provided a compound represented by a general formula (b1-1) shown below suitable as an acid generator for a resist composition, a compound represented by a general formula (I) shown below suitable as a precursor for the compound represented by the general formula (b1-1), an acid generator, a resist composition, and a method of forming a resist pattern. [Chemical Formula 1] X—Q1—Y1—SO3?M+??(I) X—Q1—Y1—SO3?A+??(b1-1) (wherein, Q1 represents a bivalent linking group or a single bond; Y1 represents an alkylene group which may contain a substituent group or a fluorinated alkylene group which may contain a substituent group; X represents an aromatic cyclic group of 5 to 30 carbon atoms which contains a fluorine atom and may contain a substituent group; M+ represents an alkali metal ion; and A+ represents an organic cation.).
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: June 7, 2011
    Assignee: Tokyo Ohka Kogyo Co., Ltd.
    Inventors: Takehiro Seshimo, Yoshiyuki Utsumi, Yoshitaka Komuro, Keita Ishiduka, Akiya Kawaue, Kyoko Ohshita
  • Publication number: 20110118154
    Abstract: A process for preparing an alkylaryl sulfonate comprising (a) reacting at least one meta-xylene compound with olefin or a mixture of olefins having from about 10 to about 20 carbon atoms, in the presence of an acid catalyst, wherein the resulting product comprises no more than 40 weight percent of 1-alkyl-2,4 dimethylsubstituted aromatic compound and at least about 60 weight percent of 1-alkyl-3,5 dimethyl substituted aromatic compound; (b) sulfonating the product of (a); and (c) neutralizing the product of (b) with a source of alkali or alkaline earth metal or ammonia.
    Type: Application
    Filed: November 19, 2009
    Publication date: May 19, 2011
    Inventors: Andrew J. Howes, Curtis Bay Campbell, Sophany Thach
  • Publication number: 20110082295
    Abstract: To develop a highly safe measure to treat Alzheimer's disease using a secretase-inhibiting substance, there is provided a compound represented by the following general formula (I) or a salt thereof: wherein A represents a phenyl group or the like, R1 represents a chlorine atom, a bromine atom, or a nitro group or the like, R2, R3, R4, and R5 each represent a hydrogen atom or the like, and L represents CH2—CH2 or CH?CH.
    Type: Application
    Filed: May 27, 2009
    Publication date: April 7, 2011
    Applicants: Tokyo Institute of Technology, Kyoto University
    Inventors: Hachiro Sugimoto, Takashi Takahashi, Ichiro Hijikuro, Michiaki Okuda
  • Publication number: 20110071178
    Abstract: Disclosed are compounds and compositions that inhibit the action of monoacylglycerol lipase (MGL) and fatty acid amide hydrolase (FAAH), methods of inhibiting MGL and FAAH, methods of modulating cannabinoid receptors, and methods of treating various disorders related to the modulation of cannabinoid receptors.
    Type: Application
    Filed: April 16, 2010
    Publication date: March 24, 2011
    Applicant: Northeastern University
    Inventors: Alexandros Makriyannis, Spyridon P. Nikas, Shakiru O. Alapafuja, Vidyanand G. Shukla
  • Publication number: 20110028751
    Abstract: Activated Supports, support-bound activators, strongly acidic supports, and silylating supports are provided; the activated support having the formula: wherein L is a linking group component; X is F, Cl, OH, and trisubstituted silyloxy; and the shaded circle represents a solid or semi-solid support. Methods of using the activated supports in solid phase organic synthesis are also provided.
    Type: Application
    Filed: April 15, 2010
    Publication date: February 3, 2011
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Christopher Holmes, Yijun Pan
  • Publication number: 20100311791
    Abstract: The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
    Type: Application
    Filed: December 28, 2007
    Publication date: December 9, 2010
    Inventors: Ramin Najafi, Rakesh K. Jain, Timothy P. Shiau, Eddy Low, Satheesh K. Nair
  • Publication number: 20100166624
    Abstract: A method of separating at least one carbon nanotube having a desired diameter and/or chirality from a mixture of carbon nanotubes having different diameters and/or chiralities is provided. A calixarene of formula (I): wherein n?4; X is PO3H2, Ra—PO3H, SO3H, or Ra—SO3H; Y is Rb, OH, or ORb; and Ra and Rb are independently selected from the group consisting of optionally substituted alkyl, optionally substituted aryl, optionally substituted arylene alkyl and optionally substituted alkylene aryl is combined with the mixture of carbon nanotubes in an aqueous solvent to produce an aqueous supernatant containing the carbon nanotube(s) having the desired diameter and/or chirality. The aqueous supernatant containing the carbon nanotube(s) is then separated from a residue comprising the remaining carbon nanotubes of the mixture.
    Type: Application
    Filed: October 30, 2009
    Publication date: July 1, 2010
    Applicant: THE UNIVERSITY OF WESTERN AUSTRALIA
    Inventors: Colin Llewellyn RASTON, Lee John Hubble
  • Patent number: 7745097
    Abstract: There are provided a novel compound represented by a general formula (b1-1) shown below, which is useful as an acid generator for a resist composition and a manufacturing method thereof, a compound useful as a precursor of the novel compound and a manufacturing method thereof, an acid generator, a resist composition and a method of forming a resist pattern.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: June 29, 2010
    Assignee: Tokyo Ohka Kogyo Co., Ltd.
    Inventors: Hideo Hada, Takeshi Iwai, Takehiro Seshimo, Akiya Kawaue, Keita Ishiduka
  • Publication number: 20100076034
    Abstract: The present invention relates to (R,S) 2-aryl-2-fluoropropanoic acids, their single enantiomers (R) and (S), their derivatives amides and acylsulfonamides and to pharmaceutical compositions containing them, which are used in the prevention and treatment of tissue damage due to the exacerbated recruitment of polymorphonucleated neutrophils (PMN leukocytes) at inflammation sites. The present invention provides compounds for use in the treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the treatment of damages caused by ischemia and reperfusion.
    Type: Application
    Filed: December 18, 2007
    Publication date: March 25, 2010
    Applicant: DOMPE PHA.R.MA S.P.A.
    Inventors: Marcello Allegretti, Andrea Aramini, Maria Candida Cesta
  • Publication number: 20090326263
    Abstract: Provided are processes for the synthesis of aniline derivatives, specifically certain aniline derivatives which have activity as thyroid receptor ligands.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 31, 2009
    Inventors: Ramakrishnan Chidambaram, Joydeep Kant, Raymond E. Weaver, Jurong Yu, Arun Ghosh
  • Publication number: 20090253761
    Abstract: Benzocycloheptyl analogs that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs, which, after phosphorylation, can behave as agonists at S1P receptors.
    Type: Application
    Filed: May 21, 2009
    Publication date: October 8, 2009
    Inventors: Kevin R. Lynch, Timothy L. Macdonald
  • Publication number: 20090171115
    Abstract: Disclosed is a method of preparing an ion dissociation functional molecule which is chemically and thermally stable under the operating conditions required in an electrochemical system such as a fuel cell and which is suitable for use as a material of, for example, a proton conductor used in a fuel cell, in a higher yield and more easily, more efficiently, more inexpensively and more safely, than by the existing art. In a second step of reacting AgOOCCF2SO2F with iodine to synthesize a raw material molecule ICF2SO2F, the reactants mixed in equimolar relation are reacted with each other at 110° C., which is higher than that in the existing art, to thereby enhance the production efficiency of the raw material molecule, then a mixed gas of the thus produced raw material molecule with carbon dioxide is pre-cooled in an exhaust passage kept at ?15° C., followed by trapping the raw material molecule by a trapping vessel cooled with dry ice, whereby the trapping efficiency for the raw material molecule is enhanced.
    Type: Application
    Filed: April 5, 2006
    Publication date: July 2, 2009
    Applicant: SONY CORPORATION
    Inventor: Yongming Li
  • Publication number: 20090163715
    Abstract: A compound represented by the general formula below or a salt thereof is a useful intermediate in the production of a [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound that has excellent cell adhesion inhibitory effect and cell invasion inhibitory effect and therefore is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases induced by the adhesion and invasion of leukocytes, such as inflammatory bowel diseases (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R1 and R2 independently represent hydrogen or a protecting group for an amino group, or R1 and R2 bond together to form an optionally substituted pyrrole ring.
    Type: Application
    Filed: May 25, 2006
    Publication date: June 25, 2009
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Mitsuo Nagai, Kazumasa Nara, Kazunori Wakasugi, Toshihiko Naito
  • Patent number: 7534911
    Abstract: A process for the preparation of Isosulphan Blue is disclosed. The process comprises the following steps: Sulphonating orthochlorobenzaldehyde, treatment with sodium sulphite, basification, condensation and oxidation to obtain Isosulphan Blue.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: May 19, 2009
    Assignee: Innovassynth Technologies (India) Ltd.
    Inventors: Balkrishna K Kulkarni, Sankar Chinnakulandai, Girish M Khandekar, Hawaldar T. Maurya, Ashok Vamanrao Arjun, Sandeep S. Sope, Sumit Kar
  • Publication number: 20090082454
    Abstract: The present application describes deuterium-enriched disufenton, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 26, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Publication number: 20090023950
    Abstract: The present invention discloses a process for producing light colored polyalkylated arylalkyl sulfonic acids. The polyalkylated arylalkyl sulfonic acids may be further neutralized with alkalis or amines to form the corresponding light colored sulfonated salts. The present invention also makes manufacture of polyalkylated arylalkyl sulfonic acids possible as first intent products using an inexpensive and simple reaction.
    Type: Application
    Filed: October 29, 2007
    Publication date: January 22, 2009
    Applicant: Oil Chem Technologies, Inc.
    Inventors: Paul D. Berger, Christie H. Berger, Guohua Cao, Oliver S. Hsu
  • Publication number: 20090004525
    Abstract: Disclosed herein are an ion-dissociative functional compound, a method for production thereof, an ionic conductor, and an electrochemical device, the ion-dissociative functional compound being thermally and chemically stable under the condition required of fuel cells and being suitable for use as a material such as protonic conductor in fuel cells. The proton-dissociative functional compound shown in FIG. 1A is composed of a fullerene C60 molecule and about 10 sulfonic acid groups —SO3H as proton-dissociative groups each attached to the fullerene through a difluoromethane group —CF2—. The proton-dissociative functional compound shown in FIG. 1B is composed of fullerene molecules three-dimensionally connected to each other through a linking group —CF2SO2NHSO2CF2—. It contains, as the proton-dissociative group, sulfoneimide groups —SO2NHSO2— and sulfoneamide groups —SO2H2 in addition to sulfonic acid groups.
    Type: Application
    Filed: August 4, 2004
    Publication date: January 1, 2009
    Inventors: Kazuaki Fukushima, Shuichi Takizawa, Koichiro Hinokuma, Atsushi Nishimoto, Kazuhiro Noda
  • Publication number: 20080227032
    Abstract: Novel classes of ionic photoacid generator (PAGs) compounds having relatively environmentally friendly anions with no perfluorooctyl sulfonate (no-PFOS) are provided and photoresist composition that comprise such compounds. The new PAGs produce a photoacid having a short or no perfluoro alkyl chain (i.e., no-PFOS) attached to a variety of functional groups. The PAGs of the invention are useful as photoactive component in the chemically amplified resist compositions used for microfabrication.
    Type: Application
    Filed: May 29, 2008
    Publication date: September 18, 2008
    Applicant: Cornell Research Foundation, Inc.
    Inventors: Christopher K. Ober, Ramakrishnan Ayothi, Kyung-Min Kim, Xiang-Qian Liu
  • Publication number: 20080207688
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Publication number: 20080102402
    Abstract: A photoresist monomer having a sulfonyl group, a polymer thereof and a photoresist composition containing the same are disclosed. The photoresist monomer is represented by following Formula. wherein, R* is a hydrogen atom or a methyl group, R1 and R2 are independently a C1˜C20 alkyl group, a C4˜C20 cycloalkyl group, a C6˜C20 aryl group or a C7˜C20 arylalkyl group, one of R1 and R2 may not exist, and R1 and R2 can be connected to form a ring.
    Type: Application
    Filed: October 24, 2007
    Publication date: May 1, 2008
    Inventors: Jung-Youl LEE, Geun-Jong Yu, Sang-Jung Kim, Jae-Woo Lee, Deog-Bae Kim, Jae-Hyun Kim
  • Patent number: 7319163
    Abstract: This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyrodism.
    Type: Grant
    Filed: June 24, 2005
    Date of Patent: January 15, 2008
    Assignee: Karo Bio AB
    Inventors: Johan Malm, Chris Litten, Theresa Apelqvist, Asa Hedfors, Peter Brandt, Karin Edvinsson, Sandra Gordon
  • Publication number: 20070191633
    Abstract: A composition for recovering oil from subterranean formation by injecting an aqueous fluid containing from about 0.05 to about 2.0% by weight of a bi-functional surfactant or a mixture of surfactants containing one or more of the following structures; Optionally the aqueous fluid may contain mixtures of individual surfactants having carboxylic, and sulfonate or sulfate functionalities. The remainder of the composition includes water or brine, a cosolvent and optionally a viscosity control agent, and optionally an alkali.
    Type: Application
    Filed: February 15, 2007
    Publication date: August 16, 2007
    Inventors: Paul Daniel Berger, Christie Huimin Berger
  • Patent number: 7256306
    Abstract: This invention relates new and improved processes for the preparation of arylalkylsulfonic acids derived from aromatic or substituted aromatic molecules and AOS acid (generally a mixture of alkenesulfonic acid and sultones, produced from the sulfonation of alpha olefins) and to cleaning compositions comprising said arylalkylsulfonic acids. The invention involves the use of a superacid catalyst to effectuate the conversion of AOS acid and aromatic reactants to arylalkylsulfonic acid under substantially anhydrous conditions, whereby a substantial improvement in the rate of conversion of the reactants to arylalkylsulfonic acid and/or improvement in mono-alkylation selectivity is realized, as compared to methods of preparation previously disclosed. Also useful as an alkylation promoter is the arylalkylsulfonic acid reaction product itself, produced in situ or from a previous reaction (i.e., a self-catalyst heel).
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: August 14, 2007
    Assignee: Stepan Company
    Inventors: Gregory P. Dado, Randal H. Bernhardt
  • Patent number: 7060697
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: June 13, 2006
    Assignee: IRM LLC
    Inventors: Thomas H. Marsilje, Nathanael S. Gray, Tao Jiang, Wenshuo Lu, Shifeng Pan
  • Patent number: 6989036
    Abstract: The present invention relates to novel reactive dyes of the formula (I) where R1 to R4 are independently hydrogen, C1–C8-alkyl, C2–C8-alkyl, wherein nonadjacent CH2 groups may be replaced by oxygen atoms or imino or C1–C4-alkylimino groups and/or CH2 groups by carbonyl groups, C2–C8-alkenyl, aryl, arylalkylene or a moiety containing a reactive group or the precursor of a reactive group, with the proviso that at least one of R1 to R4 is a moiety which contains a reactive group or the precursor of a reactive group. The present invention further relates to the use of the reactive dyes of the formula (I) for dyeing substrates containing nucleophilic groups and to preparations containing at least one reactive dye of the formula (I).
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: January 24, 2006
    Assignee: BASF Aktiengellschaft
    Inventors: Gunter-Rudolf Schröder, Helmut Reichelt, Günther Seybold, Manfred Patsch, Stevan David Jones, James Charles Dunbar, Colin John Clarke
  • Patent number: 6951706
    Abstract: The present invention provides a sulfonate of the formula (I): wherein Q1, Q2, Q3, Q4 and Q5 each independently represent hydrogen, alkyl having 1 to 16 carbon atoms, alkoxy having 1 to 16 carbon atoms, halogen, aryl having 6 to 12 carbon atoms, aralkyl having 7 to 12 carbon atoms, cyano, sulfide, hydroxy, nitro or a group of the formula (I?) —COO—X—Cy1??(I?) wherein X represents alkylene and at least one —CH2— in the alkylene may be substituted by —O— or —S—, and Cy1 represents alicyclic hydrocarbon having 3 to 20 carbon atoms, and A+ represents a counter ion, with the proviso that at least one of Q1, Q2, Q3, Q4 and Q5 is the group of the formula (I?).
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: October 4, 2005
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Satoshi Yamaguchi, Yasunori Uetani, Hiroshi Moriuma
  • Publication number: 20040242920
    Abstract: This invention relates new and improved processes for the preparation of arylalkylsulfonic acids derived from aromatic or substituted aromatic molecules and AOS acid (generally a mixture of alkenesulfonic acid and sultones, produced from the sulfonation of alpha olefins) and to cleaning compositions comprising said arylalkylsulfonic acids. The invention involves the use of a superacid catalyst to effectuate the conversion of AOS acid and aromatic reactants to arylalkylsulfonic acid under substantially anhydrous conditions, whereby a substantial improvement in the rate of conversion of the reactants to arylalkylsulfonic acid and/or improvement in mono-alkylation selectivity is realized, as compared to methods of preparation previously disclosed. Also useful as an alkylation promoter is the arylalkylsulfonic acid reaction product itself, produced in situ or from a previous reaction (i.e., a self-catalyst heel).
    Type: Application
    Filed: June 17, 2004
    Publication date: December 2, 2004
    Inventors: Gregory P Dado, Randal H Bernhardt
  • Publication number: 20040152009
    Abstract: The present invention provides a sulfonate of the formula (I): 1
    Type: Application
    Filed: August 25, 2003
    Publication date: August 5, 2004
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Satoshi Yamaguchi, Yasunori Uetani, Hiroshi Moriuma
  • Publication number: 20040152670
    Abstract: The present invention relates to therapeutically active novel aminoindanes of formula (I). Also provided is a method of preparing compounds of formula (I), and pharmaceutical compositions comprising the compounds. The novel compounds act as modulators of metabotropic glutamate receptors and, as such, are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
    Type: Application
    Filed: January 23, 2004
    Publication date: August 5, 2004
    Inventor: Kenneth Curry
  • Patent number: 6717008
    Abstract: Derivatives of C2-substituted indan-1-ol compounds, processes for their preparation and their use are disclosed. In particular, the invention relates to compounds of the formula I and to their physiologically acceptable salts and physiologically functional derivatives. The compounds are suitable, for example, for use as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: April 6, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Patent number: 6686397
    Abstract: Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed: Compositions comprising the same, methods of preparation and methods for the prophylaxis or treatment of obesity are also disclosed herein.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: February 3, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Publication number: 20040002478
    Abstract: The present invention relates to novel compounds and formulations thereof which compounds are ligands, e.g., agonists or antagonists, for a metabotropic glutamate receptor or a NAALADase enzyme or both. The present invention also relates to methods of modulating the activity of a metabotropic glutamate receptor or a NAALADase enzyme or both, e.g., in a subject in need thereof, using a compound or formulation of the present invention. The present invention also relates to methods of treating a subject suffering from a chronic or acute disease, malady or condition due at least in part to an abnormality in the activity of an endogenous metabotropic glutamate receptor or a NAALADase enzyme or both, using a compound or formulation of the present invention.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 1, 2004
    Inventors: Alan P. Kozikowski, Jarda T. Wroblewski, Fajun Nan
  • Patent number: 6670401
    Abstract: Polysubstituted indan-1-ol compounds, methods for their preparation; and methods for their use are disclosed herein. In particular, the invention relates to polysubstituted indan-1-ol compounds of the formula I and their physiologically acceptable salts. The compounds are useful, for example, as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: December 30, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel